"Nerve Sheath Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms which arise from nerve sheaths formed by SCHWANN CELLS in the PERIPHERAL NERVOUS SYSTEM or by OLIGODENDROCYTES in the CENTRAL NERVOUS SYSTEM. Malignant peripheral nerve sheath tumors, NEUROFIBROMA, and NEURILEMMOMA are relatively common tumors in this category.
| Descriptor ID |
D018317
|
| MeSH Number(s) |
C04.557.580.600 C10.551.775.500 C10.668.829.725.500
|
| Concept/Terms |
Nerve Sheath Neoplasms- Nerve Sheath Neoplasms
- Neoplasm, Nerve Sheath
- Nerve Sheath Neoplasm
- Nerve Sheath Tumors
- Tumors of the Nerve Sheath
- Neoplasms, Nerve Sheath
|
Below are MeSH descriptors whose meaning is more general than "Nerve Sheath Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Nerve Sheath Neoplasms".
This graph shows the total number of publications written about "Nerve Sheath Neoplasms" by people in this website by year, and whether "Nerve Sheath Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 3 | 5 |
| 2003 | 1 | 2 | 3 |
| 2004 | 4 | 2 | 6 |
| 2005 | 3 | 0 | 3 |
| 2006 | 6 | 0 | 6 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 4 | 0 | 4 |
| 2010 | 4 | 1 | 5 |
| 2011 | 4 | 0 | 4 |
| 2012 | 4 | 0 | 4 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 0 | 4 |
| 2015 | 2 | 0 | 2 |
| 2016 | 8 | 3 | 11 |
| 2017 | 3 | 1 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 6 | 1 | 7 |
| 2020 | 6 | 0 | 6 |
| 2021 | 7 | 1 | 8 |
| 2022 | 4 | 0 | 4 |
| 2023 | 3 | 0 | 3 |
| 2024 | 1 | 2 | 3 |
Below are the most recent publications written about "Nerve Sheath Neoplasms" by people in Profiles.
-
Multidimensional Immunotyping of Human NF1-Associated Peripheral Nerve Sheath Tumors Uncovers Tumor-Associated Macrophages as Key Drivers of Immune Evasion in the Tumor Microenvironment. Clin Cancer Res. 2024 Dec 02; 30(23):5459-5472.
-
Integrated Epigenetic and Transcriptomic Analysis Identifies Interleukin 17 DNA Methylation Signature of Malignant Peripheral Nerve Sheath Tumor Progression and Metastasis. JCO Precis Oncol. 2024 May; 8:e2300325.
-
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. Clin Cancer Res. 2024 03 01; 30(5):1038-1053.
-
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol. 2023 12 08; 25(12):2221-2236.
-
Hybrid Schwannoma-Perineurioma of the Orbit. Ophthalmic Plast Reconstr Surg. 2024 Jan-Feb 01; 40(1):e1-e4.
-
Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. Cancer Discov. 2023 03 01; 13(3):654-671.
-
Surgical Management of Peripheral Nerve Pathology in Patients With Neurofibromatosis Type 2. Neurosurgery. 2023 02 01; 92(2):317-328.
-
Plexiform Melanocytic Schwannoma: Report of a Second Case and Overview of a Rare Entity. Am J Dermatopathol. 2022 Dec 01; 44(12):943-947.
-
Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma. Elife. 2022 03 04; 11.
-
Monitoring spinal surgery for extramedullary tumors and fractures. Handb Clin Neurol. 2022; 186:245-255.